Modeling cohort | External validation cohort | |||
---|---|---|---|---|
Non-pregnancy (n = 40) | Pregnancy (n = 33) | Non-pregnancy (n = 12) | Pregnancy (n = 18) | |
Agea | 32.77 (4.95) | 32.73 (4.44) | 34.25 (4.79) | 30.72 (2.63) |
Endometrial thicknessa | 11.01 (1.95) | 12.08 (2.71) | 12.44 (2.78) | 12.03 (3.15) |
Endometrial volumea | 4.31 (1.40) | 5.21 (1.81) | 5.09 (2.07) | 5.79 (2.72) |
Endometrial morphologyc | ||||
Type A | 5(12.5%) | 2 (6.1%) | 0 (0.0%) | 3 (16.7%) |
Type B | 26 (65.0%) | 28 (84.8%) | 8 (66.7%) | 13 (72.2%) |
Type C | 9 (22.5%) | 3 (9.1%) | 4 (33.3%) | 2 (11.1%) |
Uterine artery mPIa | 2.18 (0.38) | 2.12 (0.38) | 1.97 (0.36) | 2.05 (0.50) |
Uterine artery mRIa | 0.81 (0.05) | 0.80 (0.05) | 0.78 (0.05) | 0.79 (0.05) |
Uterine artery mS/Da | 5.62 (1.44) | 5.39 (1.38) | 5.04 (1.39) | 5.01 (1.01) |
VIb | 0.67 [0.21, 1.39] | 1.05 [0.63, 2.95] | 0.18 [0.16, 0.35] | 1.34 [0.64, 3.53] |
FIa | 15.14 (3.00) | 16.03 (3.91) | 15.07 (3.86) | 17.63 (3.23) |
VFIa | 0.09 [0.03, 0.21] | 0.17 [0.07, 0.52] | 0.03 [0.02, 0.04] | 0.30 [0.11, 0.61] |
Sub-endometrial blood flowc | ||||
Type I | 18 (45.0%) | 10 (30.3%) | 8 (66.7%) | 3 (16.7%) |
Type II | 19 (47.5%) | 20 (60.6%) | 4 (33.3%) | 12 (66.7%) |
Type III | 3 (7.5%) | 3 (9.1%) | 0 (0.0%) | 3 (16.7%) |
Endometrial peristalsisc | ||||
Type I | 6 (15.0%) | 7 (21.2%) | 1 (8.3%) | 1 (5.6%) |
Type II | 1 (2.5%) | 1 (3.0%) | 1 (8.3%) | 1 (5.6%) |
Type III | 2 (5.0%) | 3 (9.1%) | 0 (0.0%) | 1 (5.6%) |
Type IV | 0 (0.0%) | 1 (3.0%) | 0 (0.0%) | 1 (5.6%) |
Type V | 31 (77.5%) | 21 (63.6%) | 10 (83.3%) | 14 (77.8%) |